Last Updated on Nov 13, 2026

Translational Cancer Research- Impact Score, Ranking, SJR, h-index, Citescore, Rating, Publisher, ISSN, and Other Important Details


Published By: AME Publishing Company

Abbreviation: Transl. Cancer Res.




Impact Score

The impact Score or journal impact score (JIS) is equivalent to Impact Factor. The impact factor (IF) or journal impact factor (JIF) of an academic journal is a scientometric index calculated by Clarivate that reflects the yearly mean number of citations of articles published in the last two years in a given journal, as indexed by Clarivate's Web of Science. On the other hand, Impact Score is based on Scopus data.

1.93

SJR

 0.524

h-Index

 47

Rank

 11374

Important Details

Title Translational Cancer Research
Standard Abbreviation Transl. Cancer Res.
Type of Publication Journal
Discipline Radiology, Nuclear Medicine and Imaging (Q2); Oncology (Q3); Cancer Research (Q4)
Impact Score 1.93
SCImago Journal Rank (SJR) 0.524
h-index 47
Overall Rank 11374
Publisher Name AME Publishing Company
Publication Country Hong Kong
International Standard Serial Number (ISSN) 22196803, 2218676X
Coverage and History 2012-2026
Best Quartile Q2
Total Citations Received
(Last 3 Year)
2478

About Translational Cancer Research


Translational Cancer Research is a journal published by AME Publishing Company. This journal covers the area[s] related to Radiology, Nuclear Medicine and Imaging, Oncology, Cancer Research, etc. The coverage history of this journal is as follows: 2012-2026. The rank of this journal is 11374. This journal's impact score, h-index, and SJR are 1.93, 47, and 0.524, respectively. The ISSN of this journal is/are as follows: 22196803, 2218676X.

The best quartile of Translational Cancer Research is Q2. This journal has received a total of 2478 citations during the last three years (Preceding 2025).


Translational Cancer Research Impact Score 2025-2026


The latest impact score (IS) of the Translational Cancer Research is 1.93. It is computed in the year 2026 as per its definition and based on Scopus data. 1.93

It is increased by a factor of around 0.31, and the percentage change is 19.14% compared to the preceding year 2024, indicating a rising trend.

The impact score (IS), also denoted as the Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting

Prediction of Translational Cancer Research Impact Score 2026


Impact Score 2025 of Translational Cancer Research is 1.93. If a similar upward trend continues, IS may increase in 2026 as well.


Impact Score Graph


Check below the Impact Score trends of Translational Cancer Research. This is based on Scopus data.


Year Impact Score (IS)
2026/2027 Coming Soon
2025 1.93
2024 1.62
2023 1.46
2022 0.81
2021 0.47
2020 0.70
2019 0.50
2018 0.38
2017 0.44
2016 1.12
2015 1.68
2014 1.83

Translational Cancer Research h-index


  Table Setting

The h-index of Translational Cancer Research is 47. By definition of the h-index, this journal has at least 47 published articles with more than 47 citations.

What is h-index?

The h-index (also known as the Hirsch index or Hirsh index) is a scientometric parameter used to evaluate the scientific impact of the publications and journals. It is defined as the maximum value of h such that the given Journal has published at least h papers and each has at least h citations.




Translational Cancer Research ISSN


The International Standard Serial Number (ISSN) of Translational Cancer Research is/are as follows: 22196803, 2218676X.

The ISSN is a unique 8-digit identifier for a specific publication like Magazine or Journal. The ISSN is used in the postal system and in the publishing world to identify the articles that are published in journals, magazines, newsletters, etc. This is the number assigned to your article by the publisher, and it is the one you will use to reference your article within the library catalogues.

ISSN code (also called as "ISSN structure" or "ISSN syntax") can be expressed as follows: NNNN-NNNC
Here, N is in the set {0,1,2,3...,9}, a digit character, and C is in {0,1,2,3,...,9,X}

Table Setting

Translational Cancer Research Ranking and SCImago Journal Rank (SJR)


The Translational Cancer Research is ranked 11374 among 27955 Journals, Conferences, and Book Series. As per SJR, this journal is ranked 0.524.

SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.


Translational Cancer Research Publisher


Table Setting

The publisher of Translational Cancer Research is AME Publishing Company. The publishing house of this journal is located in the Hong Kong. Its coverage history is as follows: 2012-2026.


Call For Papers (CFPs)


Please check the official website of this journal to find out the complete details and Call For Papers (CFPs).


Abbreviation


The International Organization for Standardization 4 (ISO 4) abbreviation of Translational Cancer Research is Transl. Cancer Res.. ISO 4 is an international standard which defines a uniform and consistent system for the abbreviation of serial publication titles, which are published regularly. The primary use of ISO 4 is to abbreviate or shorten the names of scientific journals using the technique of List of Title Word Abbreviations (LTWA).

As ISO 4 is an international standard, the abbreviation ('Transl. Cancer Res.') can be used for citing, indexing, abstraction, and referencing purposes.


How to publish in Translational Cancer Research


If your area of research or discipline is related to Radiology, Nuclear Medicine and Imaging, Oncology, Cancer Research, etc., please check the journal's official website to understand the complete publication process.


Acceptance Rate


There are several factors that influence the acceptance rate of any academic journal. Here are some critical parameters that are considered while calculating the acceptance rate:

  • Interest/demand of researchers/scientists for publishing in a specific journal/conference.
  • The complexity of the peer review process and timeline.
  • Time taken from draft submission to final publication.
  • Number of submissions received and acceptance slots
  • And Many More.

The simplest way to find out the acceptance rate or rejection rate of a Journal/Conference is to check with the journal's/conference's editorial team through emails or through the official website.



Frequently Asked Questions (FAQ)


What is the impact score of Translational Cancer Research?

The latest impact score of Translational Cancer Research is 1.93. It is computed in the year 2026.


What is the h-index of Translational Cancer Research?

The latest h-index of Translational Cancer Research is 47. It is evaluated in the year 2026.


What is the SCImago Journal Rank (SJR) of Translational Cancer Research?

The latest SCImago Journal Rank (SJR) of Translational Cancer Research is 0.524. It is calculated in the year 2026.


What is the ranking of Translational Cancer Research?

The latest ranking of Translational Cancer Research is 11374. This ranking is among 27955 Journals, Conferences, and Book Series. It is computed in the year 2026.


Who is the publisher of Translational Cancer Research?

Translational Cancer Research is published by AME Publishing Company. The publication country of this journal is Hong Kong.


What is the abbreviation of Translational Cancer Research?

This standard abbreviation of Translational Cancer Research is Transl. Cancer Res..


Is "Translational Cancer Research" a Journal, Conference or Book Series?

Translational Cancer Research is a journal published by AME Publishing Company.


What is the scope of Translational Cancer Research?

The scope of Translational Cancer Research is as follows:

  • Radiology, Nuclear Medicine and Imaging
  • Oncology
  • Cancer Research

For detailed scope of Translational Cancer Research, check the official website of this journal.


What is the ISSN of Translational Cancer Research?

The International Standard Serial Number (ISSN) of Translational Cancer Research is/are as follows: 22196803, 2218676X.


What is the best quartile for Translational Cancer Research?

The best quartile for Translational Cancer Research is Q2.


What is the coverage history of Translational Cancer Research?

The coverage history of Translational Cancer Research is as follows 2012-2026.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/
  • Issn.org, https://www.issn.org/
  • Scopus, https://www.scopus.com/

Note: The impact score shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.


Impact Score, SJR, h-Index, and Other Important metrics of These Journals, Conferences, and Book Series


Journal/Conference/Book Title Type Publisher Ranking SJR h-index Impact Score
Journal of Business Economics and Management Journal Vilnius Gediminas Technical University 12097 59 3.42
Business: Theory and Practice Journal Vilnius Gediminas Technical University 18543 35 1.68
Clinical Medicine and Research Journal Marshfield Clinic 14142 66 1.34
Istanbul University - Journal of Electrical and Electronics Engineering Journal University of Istanbul 24654 0 0.00
International Journal of Parallel, Emergent and Distributed Systems Journal Taylor and Francis Ltd. 19086 29 1.26
Journal of Education and Work Journal Brill Academic Publishers 11557 50 2.16
Educational Measurement: Issues and Practice Journal Wiley-Blackwell Publishing Ltd 6455 70 1.56
Proteomics - Clinical Applications Journal Wiley-VCH Verlag 7812 70 2.68
Metascience Journal Springer Nature 24313 3 0.00
Cardiovascular Journal of Africa Journal Clinics Cardive Publishing (PTY)Ltd 18907 45 0.51

Check complete list




Translational Cancer Research Impact Score (IS) Trend

Table: Impact Score

Year Impact Score (IS)
2026/2027 Updated Soon
2025 1.93
2024 1.62
2023 1.46
2022 0.81
2021 0.47
2020 0.70
2019 0.50
2018 0.38
2017 0.44
2016 1.12
2015 1.68
2014 1.83



Top Journals/Conferences in Radiology, Nuclear Medicine and Imaging

Clinical Research in Cardiology Supplements
Springer Verlag | Germany

Der Radiologe
Springer Verlag | Germany

See All

Top Journals/Conferences in Oncology

Cancer Microenvironment
Springer Netherlands | Netherlands

Current Colorectal Cancer Reports
Springer Science + Business Media | United States

Australian Journal of Cancer Nursing
Cambridge Media | Australia

Clinical Sarcoma Research
BioMed Central Ltd. | United Kingdom

Onkologe
Springer Verlag | Germany

Onkopediatria
Paediatrician Publishers, LLC | Russian Federation

See All

Top Journals/Conferences in Cancer Research

Cancer Microenvironment
Springer Netherlands | Netherlands

See All